Merz Pays $600M For Ultrasound Facelift Co. Ulthera
German drugmaker Merz Pharma Group announced on Thursday that it is purchasing Arizona-based Ulthera Inc., a global medical device company specializing in ultrasound technology for nonsurgical facelift treatments, for $600 million...To view the full article, register now.
Already a subscriber? Click here to view full article